These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33895854)

  • 1. Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury.
    Bohnert S; Wirth C; Schmitz W; Trella S; Monoranu CM; Ondruschka B; Bohnert M
    Int J Legal Med; 2021 Jul; 135(4):1525-1535. PubMed ID: 33895854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination.
    Olczak M; Kwiatkowska M; Niderla-Bielińska J; Chutorański D; Tarka S; Wierzba-Bobrowicz T
    Folia Neuropathol; 2018; 56(2):97-103. PubMed ID: 30509029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the risk of traumatic brain injury and evaluation neurogranin and myelin basic protein as potential biomarkers of traumatic brain injury in postmortem examination.
    Shang Y; Wang Y; Guo Y; Ren L; Zhang X; Wang S; Zhang C; Cai J
    Forensic Sci Med Pathol; 2022 Sep; 18(3):288-298. PubMed ID: 35201602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel Cerebrospinal Fluid and Serum Temporal Profile Assessment of Axonal Injury Biomarkers Neurofilament-Light Chain and Phosphorylated Neurofilament-Heavy Chain: Associations With Patient Outcome in Moderate-Severe Traumatic Brain Injury.
    Wang KKW; Barton DJ; McQuillan LE; Kobeissy F; Cai G; Xu H; Yang Z; Trifilio E; Williamson JB; Rubenstein R; Robertson CS; Wagner AK
    J Neurotrauma; 2024 Jul; 41(13-14):1609-1627. PubMed ID: 38588256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination.
    Bohnert S; Seiffert A; Trella S; Bohnert M; Distel L; Ondruschka B; Monoranu CM
    Int J Legal Med; 2020 Nov; 134(6):2167-2176. PubMed ID: 32719959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
    Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B
    J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients.
    Jakobsson J; Bjerke M; Ekman CJ; Sellgren C; Johansson AG; Zetterberg H; Blennow K; Landén M
    Neuropsychopharmacology; 2014 Sep; 39(10):2349-56. PubMed ID: 24694925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness.
    Bagnato S; Grimaldi LME; Di Raimondo G; Sant'Angelo A; Boccagni C; Virgilio V; Andriolo M
    J Neurotrauma; 2017 Aug; 34(16):2475-2479. PubMed ID: 28385104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau protein (MAPT) as a possible biochemical marker of traumatic brain injury in postmortem examination.
    Olczak M; Niderla-Bielińska J; Kwiatkowska M; Samojłowicz D; Tarka S; Wierzba-Bobrowicz T
    Forensic Sci Int; 2017 Nov; 280():1-7. PubMed ID: 28942078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of Cerebral Biomarkers Proving Traumatic Brain Injuries in Post-Mortem Body Fluids.
    Ondruschka B; Sieber M; Kirsten H; Franke H; Dreßler J
    J Neurotrauma; 2018 Sep; 35(17):2044-2055. PubMed ID: 29732941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CSF concentrations of myelin basic protein after TBI in infants and children: absence of significant effect of therapeutic hypothermia.
    Su E; Bell MJ; Kochanek PM; Wisniewski SR; Bayir H; Clark RS; Adelson PD; Tyler-Kabara EC; Janesko-Feldman KL; Berger RP
    Neurocrit Care; 2012 Dec; 17(3):401-7. PubMed ID: 22890910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroforensomics: metabolites as valuable biomarkers in cerebrospinal fluid of lethal traumatic brain injuries.
    Bohnert S; Reinert C; Trella S; Cattaneo A; Preiß U; Bohnert M; Zwirner J; Büttner A; Schmitz W; Ondruschka B
    Sci Rep; 2024 Jun; 14(1):13651. PubMed ID: 38871842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of neuron-enriched proteins as markers for traumatic brain injury in humans.
    Siman R; Toraskar N; Dang A; McNeil E; McGarvey M; Plaum J; Maloney E; Grady MS
    J Neurotrauma; 2009 Nov; 26(11):1867-77. PubMed ID: 19811094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-Based Phospho-Neurofilament-Heavy Protein as Theranostic Biomarker in Three Models of Traumatic Brain Injury: An Operation Brain Trauma Therapy Study.
    Yang Z; Zhu T; Mondello S; Akel M; Wong AT; Kothari IM; Lin F; Shear DA; Gilsdorf JS; Leung LY; Bramlett HM; Dixon CE; Dietrich WD; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM; Wang KKW
    J Neurotrauma; 2019 Jan; 36(2):348-359. PubMed ID: 29987972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute phase response after fatal traumatic brain injury.
    Ondruschka B; Schuch S; Pohlers D; Franke H; Dreßler J
    Int J Legal Med; 2018 Mar; 132(2):531-539. PubMed ID: 29306988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofluid biomarkers of traumatic brain injury.
    Agoston DV; Shutes-David A; Peskind ER
    Brain Inj; 2017; 31(9):1195-1203. PubMed ID: 28981341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
    Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
    Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration of microtubule associated protein tau (MAPT) in urine and saliva as a potential biomarker of traumatic brain injury in relationship with blood-brain barrier disruption in postmortem examination.
    Olczak M; Poniatowski ŁA; Niderla-Bielińska J; Kwiatkowska M; Chutorański D; Tarka S; Wierzba-Bobrowicz T
    Forensic Sci Int; 2019 Aug; 301():28-36. PubMed ID: 31128406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal damage is remarkable in patients with acutely worsening symptoms of compression myelopathy: biomarkers in cerebrospinal fluid samples.
    Takahashi H; Aoki Y; Nakajima A; Sonobe M; Terajima F; Saito M; Miyamoto T; Koyama K; Yamamoto K; Furuya T; Koda M; Ohtori S; Yamazaki M; Nakagawa K
    Eur Spine J; 2018 Aug; 27(8):1824-1830. PubMed ID: 29557051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing tissue damage in multiple sclerosis: a biomarker approach.
    Burman J; Zetterberg H; Fransson M; Loskog AS; Raininko R; Fagius J
    Acta Neurol Scand; 2014 Aug; 130(2):81-9. PubMed ID: 24571714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.